The human brain is the most delicate organ in nature, but brain diseases such as cerebrovascular diseases, tumors, and aneurysms always threaten human health. Traditional craniotomy surgery has significant trauma and slow recovery, and many patients miss treatment opportunities due to intolerance. In recent years, neurointerventional therapy has become a revolutionary breakthrough in the field of brain disease treatment due to its minimally invasive, precise, and efficient characteristics.
1、 Neurointervention therapy: from "radical" to "precise sniping"
Neurointervention refers to a minimally invasive technique that uses vascular puncture, catheters, guide wires, embolic materials, or drugs to accurately intervene in intracranial lesions. Compared with traditional craniotomy surgery, its advantages are obvious: only a 1-2 millimeter skin incision is required, and a pathway can be established through the femoral or radial artery to directly reach the brain lesion. Patients can get out of bed and move around within 24 hours after surgery, reducing the risk of complications by more than 60%.
The core breakthrough point lies in the leap of image navigation technology. High resolution angiography (DSA) combined with artificial intelligence algorithms can generate real-time 3D vascular models, with lesion details accurate to 0.1 millimeters at a glance. For example, a study published in Nature Medicine in 2023 showed that AI assisted navigation systems reduced catheter placement time by 40% and could automatically avoid fragile areas at the bifurcation of blood vessels, significantly reducing the risk of intraoperative bleeding.
2、 Four major technological innovations: full coverage from aneurysms to brain tumors
1. Intravascular mechanical thrombectomy: the "golden time window" to save acute cerebral infarction
The treatment core of acute ischemic stroke (cerebral infarction) is the rapid opening of occluded blood vessels. The new generation of thrombectomy stents adopts a nickel titanium alloy mesh structure, which can adapt to blood vessels of different diameters, and the thrombus grasping rate has been increased to 92% (2023 New England Journal of Medicine data). What is even more exciting is that the treatment time window has been extended from the traditional 6 hours to 24 hours, providing opportunities for patients in remote areas.
2. Blood flow guidance device: "invisible seal" for aneurysms
Once an intracranial aneurysm ruptures, the mortality rate can be as high as 30% -40%. Traditional coil embolization requires multiple surgeries, while new blood flow guidance devices such as PipeShield change the direction of blood flow through a dense mesh stent, promoting the formation of blood clots in the tumor and ultimately being absorbed by the body. According to data from the 2023 European Congress of Interventional Neuroradiology (ESMINT), this technology has increased the complete occlusion rate of large aneurysms from 65% to 89%.
3. Nanorobot drug delivery system: an "intelligent missile" that directly targets brain tumors
Malignant brain tumors such as glioblastoma are prone to developing resistance to radiotherapy and chemotherapy. In 2023, a magnetic nanorobot developed by a team from the Massachusetts Institute of Technology in the United States can cross the blood-brain barrier under magnetic field guidance and deliver chemotherapy drugs precisely to the tumor core. Animal experiments have shown that the local concentration of the drug increases by 10 times and reduces damage to normal brain tissue by 80%.
4. Biodegradable stent: a temporary "bridge" to resolve chronic stenosis
Intracranial artery stenosis is an important cause of stroke. Traditional metal stents may cause restenosis, while new polylactic acid material stents automatically degrade after supporting blood vessels for 6 months, avoiding long-term foreign body stimulation. The clinical trial in The Lancet Neurology in 2023 confirmed that its restenosis rate is 37% lower than that of metal stents.
3、 Challenge and Future: Technological Inclusion Still Needs Breakthroughs
Despite rapid progress, neurointerventional therapy still faces three major challenges:
1. High hardware costs: A composite operating room costs over 30 million yuan, limiting its widespread use in primary hospitals.
2. Long training period for doctors: Skilled neurointerventional physicians require more than 10 years of training, with a global shortage of tens of thousands of people.
3. Long term efficacy to be verified: The long-term safety of some new technologies (such as nanorobots) still needs to be tracked.
In the future, with the deep integration of materials science, robotics, and AI, neural intervention will develop towards greater intelligence and inclusiveness. It is foreseeable that innovative technologies such as microcatheter robots and autologous stem cell embolic agents may enter clinical practice in the next decade, ultimately achieving "non-invasive" treatment.
Conclusion: From "craniotomy and bone cutting" to "vascular navigation", neural intervention therapy not only changes the surgical form, but also redefines the logic of brain disease treatment. Every precise placement of the catheter is a reverence and breakthrough for the forbidden zone of human life. Perhaps in the near future, curing brain diseases will be as simple as treating a cold - this is not a fantasy, but the hope given to us by the technological revolution.